Bruin Biometrics
Bruin Biometrics makes the FDA-cleared Provizio SEM Scanner and PIPPA digital platform that detect pressure injuries 5 days before visible signs, selling to U.S. and international hospitals, academic medical centers, ICUs, oncology units, and the Veterans Administration through enterprise direct sales and a hybrid hardware-plus-SaaS-plus-services model.
- Company typePrivate
- Founded2007
- HeadquartersLos Angeles, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bruin Biometrics does
Bruin Biometrics LLC is a privately held, Los Angeles-based medical device company founded in 2007 that pioneered the clinical use of sub-epidermal moisture (SEM) scanning for early pressure injury detection. Its core product, the Provizio SEM Scanner, is an FDA-cleared handheld biocapacitance device (clearances DEN170021 in 2018 and K231830 in 2023) that measures sub-epidermal moisture at the sacrum and heels, detecting developing pressure injuries a median of 5 days before they become visible on the skin. The scanner uses an objective biomarker threshold (SEM Delta ≥0.6) and has been validated across 220+ peer-reviewed publications, 7 independent systematic reviews, and 12 global care guidelines.
The company operates a three-component system: the Provizio hardware, the PIPPA cloud-based digital health platform (HIPAA-compliant, SOC 2 Type 2, HITRUST certified, integrated with 90+ EHR systems via HL7), and the Path to Zero implementation advisory program. In late 2025 it added an AI-enabled Protocol Intelligent Assistant (PIA) that compresses protocol development from weeks to minutes and a fixed-sensor scanner variant that eliminates single-use components. Revenue is generated through a hybrid model combining scanner hardware sales, PIPPA SaaS subscriptions, professional services under Path to Zero, and a Reimbursement Support Program leveraging CMS ICD-10-PCS code XX2KXP9.
Bruin Biometrics sells via direct enterprise field sales and clinical champion models to U.S. hospitals and health systems (academic medical centers, VA, ICU, oncology, surgical and transplant units) and internationally, including UK hospices. Reported customer outcomes include 93% reduction in preventable HAPIs, 7.5x prevention ROI, and $3.4M net annual savings for an average 250-bed hospital. The company has disclosed ~$20.4M in funding across 2014–2018, has 11–50 employees, and operates with no parent company or subsidiaries.
Bruin Biometrics firmographics
Firmographics- Name
- Bruin Biometrics
- Legal name
- Bruin Biometrics LLC
- Website
- https://bruinbiometrics.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bruin Biometrics makes the FDA-cleared Provizio SEM Scanner and PIPPA digital platform that detect pressure injuries 5 days before visible signs, selling to U.S. and international hospitals, academic medical centers, ICUs, oncology units, and the Veterans Administration through enterprise direct sales and a hybrid hardware-plus-SaaS-plus-services model.
- Ownership category
- akta.pro rank
Bruin Biometrics industry classification
Industry- Product category
- Pressure Injury Prevention Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous) (HLAHACAA)
- akta.pro secondary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
Keywords
Where Bruin Biometrics is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bruin Biometrics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain
Revenue model
- Provizio SEM Scanner Hardware: Sale of FDA-cleared SEM scanning hardware device to hospitals and healthcare facilities. One-time capital purchase with ongoing sensor costs.
- PIPPA Digital Platform Subscription: Cloud-based SaaS platform subscription for SEM data management, analytics, reporting, and EHR integration. Provides real-time PI intelligence across patient, unit, and facility levels.
- Path to Zero Implementation Services: Expert advisory services, workflow design, clinical implementation, training, and ongoing support. Evidence-based PI prevention optimization program delivered alongside technology deployment.
- Reimbursement Support Program: Program to help hospitals obtain CMS reimbursement for pressure injuries identified as Present on Admission (POA) using the Provizio SEM Scanner with ICD-10-PCS procedure code XX2KXP9.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Annual | Enterprise healthcare systems |
| Outcome Based/ Performance | Annual | ROI-based value pricing |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels10 records
Bruin Biometrics product offering
Product offeringCore offering
Bruin Biometrics designs, manufactures, and sells the FDA-cleared Provizio SEM Scanner, a handheld biocapacitance device that measures Sub-Epidermal Moisture (SEM) to detect developing pressure injuries approximately 5 days (median) before visible skin signs appear. The hardware is sold to hospitals and health systems, paired with the PIPPA cloud-based digital platform for data capture, EHR integration, and reporting, plus the Path to Zero advisory program for clinical implementation.
Product overview
Bruin Biometrics offers a three-component pressure injury prevention system centered on the Provizio SEM Scanner — the only FDA-cleared device using biocapacitance to detect sub-epidermal moisture (SEM) as an early biomarker of tissue damage, identifying injuries 5 days (median) before visible signs appear. The PIPPA Digital Platform aggregates SEM scan data for real-time insights, EHR integration, and compliance reporting across 90+ systems. The Path to Zero Program provides expert implementation advisory services guiding healthcare organizations through a structured six-step methodology to adopt SEM technology and achieve zero HAPI outcomes. The Protocol Intelligent Assistant (PIA) is an AI-powered module that generates customized prevention protocols from SEM data in minutes rather than weeks. A new fixed-sensor scanner variant eliminates single-use components for sustainability.
Differentiator
Problem solved
Functional benefit
Brands
- Provizio SEM Scanner: FDA-cleared handheld SEM scanning device that detects pressure injuries 5 days (median) before visual skin assessments using biocapacitance technology to measure sub-epidermal moisture.
- PIPPA Digital Platform
- Path to Zero Program
Products and services
- Provizio SEM Scanner FDA-cleared handheld biocapacitance medical device that measures Sub-Epidermal Moisture (SEM) as an objective biomarker of developing pressure injuries, detecting tissue damage approximately 5 days (median) before visual skin assessment. Designed for use at the sacrum and heels in hospitals and healthcare facilities.
- PIPPA Digital Platform HIPAA-compliant, HITRUST and SOC 2 Type 2 certified cloud-based digital health platform that aggregates real-time SEM scan data, provides patient/unit/facility-level insights, automates reporting, and integrates with 90+ EHR systems via HL7/FHIR for pressure injury prevention and compliance documentation.
- Path to Zero Program Evidence-based implementation and clinical advisory program that guides healthcare organizations through a six-step methodology (Assess, Design, Educate, Implement, Measure, Share) to adopt SEM scanning technology, optimize prevention workflows, and achieve sustained zero HAPI outcomes.
- Protocol Intelligent Assistant (PIA) AI-enabled assistant that analyzes SEM data and clinical context to generate customized pressure injury prevention protocols, reducing protocol development time from 5–6 weeks to 5–6 minutes.
- Fixed-Sensor Provizio SEM Scanner New scanner variant that eliminates single-use sensor components to reduce medical waste and costs while maintaining FDA clearance and SEM scanning performance.
Quantifiable outcome
- 93% reduction in preventable HAPIs (systematic review of 17 studies)
- +7 more outcomes
Companies that use Bruin Biometrics
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
Bruin Biometrics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature6 records
Bruin Biometrics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- NPIAP (National Pressure Injury Advisory Panel)corePIPPA platform integrates NPIAP's Standardized Pressure Injury Prevention Protocol (SPIPP) Checklist 2.0, embedding clinical best practices into the digital workflow for standardized PI prevention protocols.
- Epic Systems CorporationcorePIPPA platform integrates with Epic EHR systems for automated SEM Delta data capture, intervention documentation, and eCQM reporting. SEM scan data flows seamlessly into Epic workflows, eliminating manual data entry and supporting POA documentation.
- HL7 InternationalcoreHL7 FHIR standards support for EHR integration across 90+ systems, enabling interoperability and automated data exchange for SEM scan results.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
Bruin Biometrics competitors and assessment
Company assessmentBroad incumbents
- Arjo: Arjo provides patient handling and pressure-injury prevention surfaces (e.g., Auralis, AtmosAir) used widely in hospitals and long-term care. It overlaps with Bruin Biometrics on the pressure-injury prevention workflow but competes via reactive support surfaces rather than early objective detection.
- Stryker (Sage Products): Stryker acquired Sage Products, a maker of pressure-injury prevention skin care and preps, and offers a broad acute-care portfolio. It competes with Bruin Biometrics in pressure-injury prevention but again via products and surfaces, not biocapacitance-based SEM scanning.
- ConvaTec: ConvaTec's Advanced Wound Care division supplies dressings, negative-pressure wound therapy, and skin-care products used in pressure-injury prevention and treatment. It is a comparable enterprise sales motion targeting the same hospital decision-makers.
- 3M Health Care (Solventum / KCI): 3M's Health Care business (spun off as Solventum, including KCI V.A.C. therapy) is a major wound-care and hospital products incumbent. It overlaps with Bruin Biometrics in hospital pressure-injury workflows but addresses them through dressings and NPWT rather than early detection.
- Smith+Nephew: Smith+Nephew is a major advanced wound management player (ALLEVYN, PICO negative-pressure wound therapy). It competes with Bruin Biometrics in pressure-injury treatment economics rather than early detection, but targets the same hospital budgets and quality leaders.
- Hill-Rom (now part of Baxter): Hill-Rom (acquired by Baxter) is a dominant supplier of hospital beds and pressure-injury prevention surfaces such as the ICON and Centrella lines. It competes with Bruin Biometrics in pressure-injury prevention broadly but lacks an FDA-cleared objective tissue-damage detection device like the Provizio SEM Scanner.
- Coloplast: Coloplast's Wound Care division provides dressings and skin-care products for pressure-injury prevention and treatment. It competes for the same hospital wound-care budget allocation as Bruin Biometrics, though with a focus on treatment rather than early biomarker detection.
Emerging players
- Tissue Analytics (a Net Health company): Tissue Analytics, now part of Net Health, offers AI-powered digital wound imaging, measurement, and EHR-integrated documentation. It competes with PIPPA in the digital pressure-injury workflow and EHR-integration layer for wound care.
- MolecuLight: MolecuLight makes handheld point-of-care fluorescence imaging devices for real-time wound bacterial burden assessment. It is an emerging digital wound-assessment player with a similar bedside-handheld, objective-detection value proposition to Provizio.
Direct peers
- Mölnlycke Health Care: Mölnlycke is a leading global wound-care and pressure-injury prevention company (Mepilex Border, Mepitel, etc.). It addresses pressure-injury management through dressings and prevention protocols and is a natural comparison point for Bruin Biometrics' clinical workflow in hospitals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Bruin Biometrics social profiles
Digital presenceBruin Biometrics compliance and trust
Trust signalCompliance5 records
Bruin Biometrics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bruin Biometrics leadership team
Management profileNumber of profiles
Profiles7 records
Bruin Biometrics funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bruin Biometrics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bruin Biometrics
What does Bruin Biometrics do?
Bruin Biometrics designs, manufactures, and sells the FDA-cleared Provizio SEM Scanner, a handheld biocapacitance device that measures Sub-Epidermal Moisture (SEM) to detect developing pressure injuries approximately 5 days (median) before visible skin signs appear. The hardware is sold to hospitals and health systems, paired with the PIPPA cloud-based digital platform for data capture, EHR integration, and reporting, plus the Path to Zero advisory program for clinical implementation.
Is Bruin Biometrics a public or private company?
Bruin Biometrics is a private company. It is classified as unknown and is currently operating.
When was Bruin Biometrics founded?
Bruin Biometrics was founded in 2007. It employs 11 to 50 people.
Where is Bruin Biometrics based?
Bruin Biometrics is headquartered in Los Angeles, United States, in the North America region.
How does Bruin Biometrics make money?
Four revenue lines are on record. Provizio SEM Scanner Hardware is the primary driver. The others are PIPPA Digital Platform Subscription, path to Zero Implementation Services and reimbursement Support Program.
Who are Bruin Biometrics's main competitors?
Broad incumbents on record are Arjo, Stryker (Sage Products), ConvaTec, 3M Health Care (Solventum / KCI), Smith+Nephew, Hill-Rom (now part of Baxter) and Coloplast. Emerging players are Tissue Analytics (a Net Health company) and MolecuLight. Mölnlycke Health Care is listed as a direct peer.
Does Bruin Biometrics have an API?
No public API is recorded for Bruin Biometrics.
What industry is Bruin Biometrics in?
Bruin Biometrics's product category is Pressure Injury Prevention Medical Devices. Its primary akta.pro industry code is HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.